Geskin L - Search Results

1

Adverse effects of denileukin diftitox and their management in patients with cutaneous T-cell lymphoma.

McCann S, Akilov OE, Geskin L. McCann S, et al. Among authors: geskin l. Clin J Oncol Nurs. 2012 Oct;16(5):E164-72. doi: 10.1188/12.CJON.E164-E172. Clin J Oncol Nurs. 2012. PMID: 23022942 Review.

2

ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.

Geskin L. Geskin L. Skin Therapy Lett. 2007 Jun;12(5):1-4. Skin Therapy Lett. 2007. PMID: 17609808 Free article. Review.

3

Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma.

Duvic M, Olsen EA, Breneman D, Pacheco TR, Parker S, Vonderheid EC, Abuav R, Ricker JL, Rizvi S, Chen C, Boileau K, Gunchenko A, Sanz-Rodriguez C, Geskin LJ. Duvic M, et al. Among authors: geskin lj. Clin Lymphoma Myeloma. 2009 Dec;9(6):412-6. doi: 10.3816/CLM.2009.n.082. Clin Lymphoma Myeloma. 2009. PMID: 19951879 Clinical Trial.

4

Infectious agents in cutaneous T-cell lymphoma.

Mirvish ED, Pomerantz RG, Geskin LJ. Mirvish ED, et al. J Am Acad Dermatol. 2011 Feb;64(2):423-31. doi: 10.1016/j.jaad.2009.11.692. Epub 2010 Aug 7. J Am Acad Dermatol. 2011. PMID: 20692726 Free PMC article. Review.

5

Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells.

Akilov OE, Wu MX, Jin Y, Zhou Z, Geskin LJ, Falo LD, Hasan T. Akilov OE, et al. Photodermatol Photoimmunol Photomed. 2011 Apr;27(2):97-107. doi: 10.1111/j.1600-0781.2011.00578.x. Photodermatol Photoimmunol Photomed. 2011. PMID: 21392113 Free PMC article.

6

Therapeutic advances in cutaneous T-cell lymphoma.

Akilov OE, Geskin L. Akilov OE, et al. Among authors: geskin l. Skin Therapy Lett. 2011 Feb;16(2):1-5. Skin Therapy Lett. 2011. PMID: 21591544 Free PMC article. Review.

7

Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.

Akilov OE, Pillai RK, Grandinetti LM, Kant JA, Geskin L. Akilov OE, et al. Among authors: geskin l. Arch Dermatol. 2011 Aug;147(8):943-7. doi: 10.1001/archdermatol.2011.187. Arch Dermatol. 2011. PMID: 21844453 Free PMC article.

8

Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions.

Akilov OE, Grant C, Frye R, Bates S, Piekarz R, Geskin LJ. Akilov OE, et al. Among authors: geskin lj. Br J Dermatol. 2012 Jul;167(1):194-7. doi: 10.1111/j.1365-2133.2012.10905.x. Br J Dermatol. 2012. PMID: 22372971 Free PMC article. Clinical Trial.

9

Resistance of Sézary cells to TNF-α-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression.

Akilov OE, Wu MX, Ustyugova IV, Falo LD Jr, Geskin LJ. Akilov OE, et al. Exp Dermatol. 2012 Apr;21(4):287-92. doi: 10.1111/j.1600-0625.2012.01452.x. Exp Dermatol. 2012. PMID: 22417305 Free PMC article.

10

Cutaneous manifestations of unspecified peripheral T-cell lymphoma may be indicative of disease activity and predict response to therapy.

Schowalter MK, Akilov OE, Story SK, Geskin LJ. Schowalter MK, et al. J Clin Oncol. 2012 Oct 1;30(28):e283-5. doi: 10.1200/JCO.2012.41.6644. Epub 2012 Aug 6. J Clin Oncol. 2012. PMID: 22869871 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page